ASTELLAS PHARMA UNSP.ADR (YPHA) — Cash Flow Quality Index
ASTELLAS PHARMA UNSP.ADR (YPHA) has a Cash Flow Quality Index of 0.61x as of March 2025. Operating cash flow of €194.51 Billion is below net income of €319.72 Billion, suggesting accrual-heavy earnings not yet converted to cash. Also explore balance sheet size of ASTELLAS PHARMA UNSP.ADR for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
ASTELLAS PHARMA UNSP.ADR Cash Flow Quality Index (2022–2025)
Historical Cash Flow Quality Index for ASTELLAS PHARMA UNSP.ADR across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check ASTELLAS PHARMA UNSP.ADR (YPHA) tangible net worth to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for ASTELLAS PHARMA UNSP.ADR (2022–2025)
Year-by-year earnings quality comparison for ASTELLAS PHARMA UNSP.ADR. For live market cap and the full company financial profile, see YPHA company net worth.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.61x | €194.51 Billion | €319.72 Billion | ▲ +3.1% |
| 2024 | 0.59x | €172.47 Billion | €292.16 Billion | ▼ -82.2% |
| 2023 | 3.32x | €327.77 Billion | €98.71 Billion | ▲ +190.3% |
| 2022 | 1.14x | €257.44 Billion | €225.09 Billion | — |